在阿尔茨海默病（Alzheimer's disease，AD）的研究领域，一直存在着诸多谜团等待科学家们去解开。淀粉样蛋白 β（Amyloid-beta，Aβ）和 tau 蛋白的沉积，是 AD 的标志性病理特征 ，可这些病理变化往往在临床症状出现前许多年就已悄然开始。如今，针对 AD 的疾病修饰疗法，比如抗 Aβ 和抗 tau 抗体疗法不断涌现，这就使得在疾病的临床前期实现早期检测和精准预测 AD ...

Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor ...

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine repeat expansion within the huntingtin protein. HD is characterized by problems with ...

A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...

A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...

Nedlands-based biotech company PYC Therapeutics has received approvals to start human trials over a drug candidate for kidney ...